Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells

This publication has 23 references indexed in Scilit:

• Circulating concentrations of insulin-like growth factor I and risk of breast cancer
  The Lancet, 1998
• Apoptotic Regression of MCF-7 Xenografts in Nude Mice Treated with the Vitamin D3 Analog, EB1089
  Endocrinology, 1998
• Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention
  Breast Cancer Research and Treatment, 1998
• Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells
  Journal of Endocrinology, 1997
• The IGF-I receptor in cell growth, transformation and apoptosis
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
• Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089
  European Journal Of Cancer, 1996
• Suppression of Interleukin-1β-converting Enzyme-mediated Cell Death by Insulin-like Growth Factor
  Published by Elsevier ,1996
• 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo
  Breast Cancer Research and Treatment, 1993
• C-fos, C-jun and C-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells
  Biochemical and Biophysical Research Communications, 1992
• Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitro
  Biochemical Pharmacology, 1992